ANAVEX LIFE SCIENCES CORPANAVEX LIFE SCIENCES CORPANAVEX LIFE SCIENCES CORP

ANAVEX LIFE SCIENCES CORP

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪304.60 M‬EUR
−0.46EUR
‪−44.94 M‬EUR
‪81.97 M‬
Beta (1Y)
1.93

About Anavex Life Sciences Corp.

CEO
Christopher U. Missling
Website
Headquarters
New York
Employees (FY)
40
Founded
2004
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 12X1 is 3.57 EUR — it has increased by 4.54% in the past 24 hours. Watch ANAVEX LIFE SCIENCES CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ANAVEX LIFE SCIENCES CORP stocks are traded under the ticker 12X1.
ANAVEX LIFE SCIENCES CORP is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
12X1 stock is 4.44% volatile and has beta coefficient of 1.93. Track ANAVEX LIFE SCIENCES CORP stock price on the chart and check out the list of the most volatile stocks — is ANAVEX LIFE SCIENCES CORP there?
12X1 earnings for the last quarter are −0.12 EUR per share, whereas the estimation was −0.10 EUR resulting in a −18.18% surprise. The estimated earnings for the next quarter are −0.13 EUR per share. See more details about ANAVEX LIFE SCIENCES CORP earnings.
ANAVEX LIFE SCIENCES CORP revenue for the last quarter amounts to 0 EUR despite the estimated figure of 0 EUR. In the next quarter revenue is expected to reach 0 EUR.
Yes, you can track ANAVEX LIFE SCIENCES CORP financials in yearly and quarterly reports right on TradingView.
12X1 stock has risen by 0.20% compared to the previous week, the month change is a 13.82% fall, over the last year ANAVEX LIFE SCIENCES CORP has showed a 58.77% decrease.
12X1 net income for the last quarter is ‪−9.77 M‬ EUR, while the quarter before that showed ‪−7.81 M‬ EUR of net income which accounts for −25.12% change. Track more ANAVEX LIFE SCIENCES CORP financial stats to get the full picture.
Today ANAVEX LIFE SCIENCES CORP has the market capitalization of ‪304.60 M‬, it has increased by 5.08% over the last week.
No, 12X1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 12X1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANAVEX LIFE SCIENCES CORP stock right from TradingView charts — choose your broker and connect to your account.
12X1 reached its all-time high on Jun 28, 2021 with the price of 27.40 EUR, and its all-time low was 0.55 EUR and was reached on Jul 26, 2007. View more price dynamics on 12X1 chart.
See other stocks reaching their highest and lowest prices.
As of May 10, 2024, the company has 40.00 employees. See our rating of the largest employees — is ANAVEX LIFE SCIENCES CORP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANAVEX LIFE SCIENCES CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANAVEX LIFE SCIENCES CORP stock shows the sell signal. See more of ANAVEX LIFE SCIENCES CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ANAVEX LIFE SCIENCES CORP future price: according to them, 12X1 price has a max estimate of 37.10 EUR and a min estimate of 13.91 EUR. Watch 12X1 chart and read a more detailed ANAVEX LIFE SCIENCES CORP stock forecast: see what analysts think of ANAVEX LIFE SCIENCES CORP and suggest that you do with its stocks.